Gene Therapy Aims for a Cure by Silencing Hepatitis B DNA, Pg13

Key Highlights:

• Scientists have developed a new gene therapy, CRMA-1001, for Hepatitis B, reported in Nature Biomedical Engineering.
• The therapy aims for a functional cure by silencing the viral DNA through epigenetic control, rather than directly targeting the virus.
• CRMA-1001 utilizes a CRISPR-Cas9 based 'locator' to target viral DNA and an 'effector' to add methyl groups, delivered via an mRNA platform.
• In mouse models, the treatment significantly reduced Hepatitis B viral markers and DNA levels, achieving up to 90% suppression after multiple doses.
• This approach offers a potential solution to the virus's ability to rebound from current treatments that do not eliminate its DNA.

Gene Therapy.jpg

Detailed Insights:

• Current treatments for Hepatitis B often fail to eliminate the viral DNA, allowing the virus to persist silently in liver cells and reactivate later.
• The virus can 'hide' from the immune system by methylating cytosines in its DNA, which silences its genes and prevents new virus production.
• CRMA-1001 specifically targets and methylates the viral genome, preventing the cell's machinery from reading the viral genes.
• The 'locator' component of CRMA-1001 uses CRISPR-Cas9 to precisely identify and bind to a specific sequence within the viral DNA.
• The 'effector' component then adds methyl groups to nearby cytosines and includes proteins that help switch off the viral genes.
• A functional cure implies that the virus is thoroughly suppressed to undetectable levels, eliminating active disease signs, even if the viral DNA remains present.
• An ongoing Phase I/II clinical trial is further investigating the long-term effects and potential for viral reactivation of CRMA-1001.

Scientific/Technical Concepts Involved:

• Epigenetic Control: Changes in gene activity that do not involve alterations to the underlying DNA sequence.
• DNA Methylation: A biochemical process where a methyl group is added to a DNA base, typically cytosine, often leading to gene silencing.
• CRISPR-Cas9: A powerful gene-editing tool that allows precise targeting and modification of specific DNA sequences.
• mRNA Platform: A technology that delivers messenger RNA into cells, instructing them to produce specific proteins for therapeutic purposes.
• Functional Cure: A state in chronic viral infections where the virus is suppressed to undetectable levels, and the patient shows no active disease symptoms.